Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Assessing allergic rhinitis in developing countries
International Journal of Tuberculosis and Lung Disease, Volume 14, No. 4, Year 2010
Notification
URL copied to clipboard!
Description
BACKGROUND: Allergic rhinitis (AR) affects 5% to 40% of the general population. In developing countries, AR is poorly documented and tracked due to a lack of appropriate diagnostic tools. OBJECTIVE: 1) To validate a questionnaire standardised in industrialised countries to ascertain AR, the Score For Allergic Rhinitis (SFAR), in developing countries; 2) to better understand AR prevalence previously reported from developing countries by comparing results from the SFAR and the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires. METHODS: Six African countries were selected for their climates. In each country, 70 individuals with and 30 without nasal symptoms fi lled out the SFAR and the ISAAC questionnaires. Skin prick tests (SPTs) for allergens were performed by the physician if necessary. RESULTS: The SFAR presented a close match with the gold standard (the physician's diagnosis of AR backed up by SPT where necessary) in terms of various performance parameters. In particular, it showed high sensitivity (0.84) and specifi city (0.81). Compared to the ISAAC questionnaire, the SFAR had greater sensitivity and equal specifi city. CONCLUSIONS: In the absence of a medical visit, the SFAR is a useful standardised screening instrument for the collection of information needed for the identification of AR in developing countries. © 2010 The Union.
Authors & Co-Authors
Piau, Jean Pierre
France, Paris
Inserm
France, Paris
Sorbonne Université
Massot, C.
France, Paris
Inserm
Moreau, D.
France, Paris
Inserm
France, Paris
Sorbonne Université
Aït-Khaled, Nadia
France, Paris
International Union Against Tuberculosis and Lung Disease
Bouayad, Z.
Morocco, Casablanca
Centre Hospitalière Universitaire Chu
Mohammad, Yousser
Syrian Arab Republic, Damascus
Chu
Khaldi, Faouzia
Tunisia, Tunis
Université de Tunis el Manar, Hôpital D'enfants Béchir Hamza de Tunis
Bah Sow, Oumou
Guinea
Chu
Camara, Lansana Mady
Guinea
Chu
Koffi, Nguran B.
Cote D'ivoire, Abidjan
Chu
M'Boussa, J.
Congo, Brazzaville
Centre Hospitalier et Universitaire de Brazzaville
El-Sony, Asma I.
Sudan, Khartoum
University of Khartoum Faculty of Medicine
Moussa, O. A.
Sudan, Khartoum
University of Khartoum Faculty of Medicine
Bousquet, Jean J.
France, Montpellier
Hopital Arnaud de Villeneuve
Annesi-Maesano, Isabella I.
France, Paris
Inserm
France, Paris
Sorbonne Université
Statistics
Citations: 15
Authors: 15
Affiliations: 11
Identifiers
ISSN:
10273719
Research Areas
Maternal And Child Health
Study Design
Cross Sectional Study